Detalles de la búsqueda
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33951374
2.
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Lancet Microbe
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38878794
3.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV
; 9(5): e309-e322, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489376
Resultados
1 -
3
de 3
1
Próxima >
>>